Oppenheimer Downgrades Bioceres Crop Solutions (BIOX) to Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts BIOX Hot Sheet
Price: $0.22 -4.35%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 41
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 41
Join SI Premium – FREE
Oppenheimer analyst Kristen Owen downgraded Bioceres Crop Solutions (NASDAQ: BIOX) from Outperform to Perform.
For an analyst ratings summary and ratings history on Bioceres Crop Solutions click here. For more ratings news on Bioceres Crop Solutions click here.
Shares of Bioceres Crop Solutions closed at $1.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Reviews Coverage List in Light of Anthropic (ANT) S-1
- Aspira Plastic Surgery & Med Spa Offers Savings on Liposuction and Complimentary Consultations
- Merck drug cuts death risk by 32% in endometrial cancer trial
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
